Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

NOV 11, 2014 - Yahoo! News

A Must Read - Share

Amgen psoriasis drug tops J&J's Stelara in Phase III study

(Reuters) - Amgen Inc said on Tuesday that its experimental psoriasis drug, brodalumab, met all the goals of a late-stage study, clearing the rough skin patches associated with the disease more thoroughly than Johnson & Johnson's Stelara and a placebo. Amgen is developing brodalumab under a multi-drug collaboration with AstraZeneca that involves splitting costs and eventual profits. After 12 weeks ...

Tags: Amgen psoriasis drug tops J&J's Stelara in Phase III study,  Amgen Latest News

NOV 07, 2014 - Yahoo! News

A Must Read - Share

EU plans risk reduction steps for Servier, Amgen heart drug

LONDON (Reuters) - Experts at the European Medicines Agency have recommended measures to reduce the risks associated with a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year. Ivabradine is not currently approved in the United States but it is sold in Europe for treating stable angina, ...

Tags: EU plans risk reduction steps for Servier, Amgen heart drug,  Amgen Latest News

NOV 04, 2014 - Yahoo! News

A Must Read - Share

Amgen ovarian cancer drug fails to improve overall survival

(Reuters) - Amgen Inc said its experimental ovarian cancer drug did not show statistically significant improvement in overall survival rate in a late-stage trial. Patients given the drug, trebananib, along with a chemotherapy agent paclitaxel, experienced overall survival of 19.3 months, compared with 18.3 months for the placebo group. Statistically significant improvement in overall survival was the secondary goal of ...

Tags: Amgen ovarian cancer drug fails to improve overall survival,  Amgen Latest News